Literature DB >> 21918049

Clinical utility of dual-energy CT for evaluation of tophaceous gout.

Madhura A Desai1, Jeffrey J Peterson, Hillary Warren Garner, Mark J Kransdorf.   

Abstract

Although diagnosing gout generally is straightforward, atypical disease may present a challenge if it is associated with unusual symptoms or sites, discordant serum urate level, or mimics of gout. Dual-energy computed tomography (CT) may be used to differentiate urate crystals from calcium by using specific attenuation characteristics, which may help diagnose gout. In patients with known tophaceous gout, dual-energy CT may be used for serial volumetric quantification of subclinical tophi to evaluate response to treatment. Given the utility of dual-energy CT in challenging cases and its ability to provide an objective outcomes measure in patients with tophaceous gout, dual-energy CT promises to be a unique and clinically relevant modality in the diagnosis and management of gout.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21918049     DOI: 10.1148/rg.315115510

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  40 in total

Review 1.  Basic radiological assessment of synovial diseases: a pictorial essay.

Authors:  Aynur Turan; Pınar Çeltikçi; Abdurrahman Tufan; Mehmet Akif Öztürk
Journal:  Eur J Rheumatol       Date:  2016-01-29

Review 2.  Axial (spinal) gout.

Authors:  Elena Lumezanu; Rukmini Konatalapalli; Arthur Weinstein
Journal:  Curr Rheumatol Rep       Date:  2012-04       Impact factor: 4.592

Review 3.  Imaging in gout: A review of the recent developments.

Authors:  Priya Varghese Chowalloor; Teck K Siew; Helen Isobel Keen
Journal:  Ther Adv Musculoskelet Dis       Date:  2014-08       Impact factor: 5.346

4.  Unusual Presentation of Gout: Intratendinous Tophus in the Patellar Tendon.

Authors:  Canan Cimşit; Onur Buğdayci; Mustafa Erkin Aribal
Journal:  Arch Rheumatol       Date:  2015-11-03       Impact factor: 1.472

5.  2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Authors:  Dinesh Khanna; John D Fitzgerald; Puja P Khanna; Sangmee Bae; Manjit K Singh; Tuhina Neogi; Michael H Pillinger; Joan Merill; Susan Lee; Shraddha Prakash; Marian Kaldas; Maneesh Gogia; Fernando Perez-Ruiz; Will Taylor; Frédéric Lioté; Hyon Choi; Jasvinder A Singh; Nicola Dalbeth; Sanford Kaplan; Vandana Niyyar; Danielle Jones; Steven A Yarows; Blake Roessler; Gail Kerr; Charles King; Gerald Levy; Daniel E Furst; N Lawrence Edwards; Brian Mandell; H Ralph Schumacher; Mark Robbins; Neil Wenger; Robert Terkeltaub
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-10       Impact factor: 4.794

Review 6.  [The etiology and management of gout].

Authors:  B Pazár Maldonado; A So
Journal:  Z Rheumatol       Date:  2012-02       Impact factor: 1.372

7.  Visualization of joint and bone using dual-energy CT arthrography with contrast subtraction: in vitro feasibility study using porcine joints.

Authors:  Jee Won Chai; Jung-Ah Choi; Ja-Young Choi; Sujin Kim; Sung Hwan Hong; Heung Sik Kang
Journal:  Skeletal Radiol       Date:  2014-01-25       Impact factor: 2.199

Review 8.  Peering through the glare: using dual-energy CT to overcome the problem of metal artefacts in bone radiology.

Authors:  Tyler M Coupal; Paul I Mallinson; Patrick McLaughlin; Savvas Nicolaou; Peter L Munk; Hugue Ouellette
Journal:  Skeletal Radiol       Date:  2014-01-17       Impact factor: 2.199

9.  Severe Carpal Tunnel Syndrome Caused by Gouty Tophi Diagnosed by Dual Energy Computed Tomography: Case Report.

Authors:  Yan Ge; Fen Li; Jinwei Chen; Jing Tian
Journal:  Arch Rheumatol       Date:  2016-05-17       Impact factor: 1.472

10.  Methods of assessment of tophus and bone erosions in gout using dual-energy CT: reproducibility analysis.

Authors:  Dan Shi; Jian-Xia Xu; Hua-Xiang Wu; Ying Wang; Qi-Jing Zhou; Ri-Sheng Yu
Journal:  Clin Rheumatol       Date:  2014-06-17       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.